Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood or Adipose Tissue
Mesenchymal stem cells (MSC) represent a promising tool for new clinical concepts
in supporting cellular therapy. Bone marrow (BM) was the first source reported to
contain MSC. However, for clinical use BM may be detrimental due to the highly
invasive donation procedure and the decline in MSC number and differentiation
potential with increasing age. More recently, umbilical cord blood (UCB), attainable
by a less invasive method, was introduced as an alternative source for MSC. Another
promising source is adipose tissue (AT). We compared MSC derived from these
sources regarding morphology, the success rate to isolate MSC, colony-frequency,
expansion potential, multiple differentiation capacity and immune phenotype.
No significant differences concerning the morphology and immuno phenotype of the
MSC derived from these sources were obvious. Differences could be observed
concerning the success rate of isolating MSC, which was 100% for BM and AT, but
only 63% for UCB. The colony-frequency was lowest from UCB whereas it was
highest from AT. However, UCB-MSC could be cultured longest and showed the
highest proliferation capacity, whereas BM-MSC possessed the shortest culture
period and the lowest proliferation capacity. Most strikingly, UCB-MSC showed no
adipogenic differentiation capacity, in contrast to BM- or AT-MSC.
Both UCB and AT are attractive alternatives to BM in isolating MSC: AT as it contains
MSC at highest frequency and UCB as it seems to be expandable to higher numbers.